Feedback / Questions
sepetaprost (DE-126) - Santen
Sepetaprost: Completion of P2b study for glaucoma in H1 2018
(Santen)
-
Feb 7, 2018 -
Q3 FY2017 Results
Trial completion date
•
Glaucoma • Ophthalmology
http://www.santen.com/en/ir/document/pdf/mtg2018_3q.pdf
Feb 7, 2018
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious